Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00414661 · ClinicalTrials.gov registry record

Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550

A clinical trial of Arthritis, Rheumatoid, sponsored by Pfizer.

Completed
Registry status
162
Enrollment target
20
Study locations

NCT00414661: Completed study of Arthritis, Rheumatoid, sponsored by Pfizer.

NCT00414661 is a study of Arthritis, Rheumatoid that has completed, run by Pfizer. The registered enrollment target is 162 participants, below the 635-participant average among 27 other Arthritis, Rheumatoid trials with a reported enrollment target (74% lower). The trial reports 20 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00414661, a study of Arthritis, Rheumatoid, has completed, sponsored by Pfizer.

COMPLETED
Registry status
162 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to follow the health of subjects who have previously been enrolled in studies of CP-690,550 for treatment of their rheumatoid arthritis. Subjects are only eligible for this study after they have completed all participation in other studies of CP-690,550.

Primary Outcome

Incidence rate was calculated separately for active treatment period and follow-up period in previous studies as number of participants with LPD by number of days while on active treatment or during follow-up period per 100 person-years. Standardization of incidence rates was based upon the age and sex distribution of the entire study population.

Conditions Studied

Arthritis, Rheumatoid

Interventions

  • DRUG CP-690,550

Study Locations (20)

Florida

  • Pfizer Investigational Site - Ocala
  • Pfizer Investigational Site - Orlando
  • Pfizer Investigational Site - Sarasota
  • Pfizer Investigational Site - Tampa
  • Pfizer Investigational Site - Tampa
  • Pfizer Investigational Site - Venice

California

  • Pfizer Investigational Site - Palo Alto
  • Pfizer Investigational Site - San Diego
  • Pfizer Investigational Site - Stanford
  • Pfizer Investigational Site - Upland

Arizona

  • Pfizer Investigational Site - Gilbert
  • Pfizer Investigational Site - Tucson

North Carolina

  • Pfizer Investigational Site - Hickory
  • Pfizer Investigational Site - Hickory

Illinois

  • Pfizer Investigational Site - Rockford

Nebraska

  • Pfizer Investigational Site - Lincoln

New York

  • Pfizer Investigational Site - Albany

Pennsylvania

  • Pfizer Investigational Site - Wyomissing

Trial Details

FieldValue
Enrollment Target 162 participants
Start Date 2007-04
Est. Completion 2012-02
Pfizer

1,845 total trials

What the finished NCT00414661 record still lists

NCT00414661 is an observational study that tracks outcomes without assigning an intervention. The registered 162 participants enrollment target is mid-sized for trials with a published cap, below the 635-participant average among 27 other Arthritis, Rheumatoid trials with a reported enrollment target (74% lower).

The record links to 1 condition, with Arthritis, Rheumatoid appearing as the primary indexed condition, and to 1 intervention - of which CP-690,550 is the first listed.

NCT00414661 names 20 study sites across 10 states, led by Florida, California, Arizona.

Frequently Asked Questions

What is clinical trial NCT00414661 about?

NCT00414661 is a clinical study titled "Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550". The purpose of this study is to follow the health of subjects who have previously been enrolled in studies of CP-690,550 for treatment of their rheumatoid arthritis. Subjects are only eligible for this study after they have completed all participation in other studies of CP-690,550.

What is the current status of trial NCT00414661?

This trial is currently completed. The enrollment target is 162 participants. The study started on 2007-04. Estimated completion is 2012-02.

What conditions does trial NCT00414661 study?

This clinical trial studies the following conditions: Arthritis, Rheumatoid.

What interventions are being tested in trial NCT00414661?

The interventions under investigation include: CP-690,550 (DRUG).

Who is sponsoring clinical trial NCT00414661?

This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00414661 being conducted?

This trial has 20 study locations across Arizona, California, Florida, Illinois, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Arthritis, Rheumatoid

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00414661's enrollment target sits among peer trials

162 19th of 27 higher than 9 of 27 other Arthritis, Rheumatoid trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Arthritis, Rheumatoid trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02347111 · 162 participants · Phase 4

    Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation

  • NCT02610426 · 162 participants

    Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer

  • NCT05040711 · 162 participants · NA

    mHealth Mindfulness With Patients With Serious Illness and Their Caregivers

  • NCT05514717 · 162 participants · Phase 1

    A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT00414661, the US trial registry maintained by the National Library of Medicine. NCT00414661 (mid enrollment · wide site footprint · completed) retrieved and formatted by PlainTrial, see methodology.